about
Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3XIdentification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope proteinHepatitis C Virus 3'X Region Interacts with Human Ribosomal ProteinsAntigenic heterogeneity of the hepatitis C virus NS5A protein.Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymeraseSecondary Structure of the 3' Terminus of Hepatitis C Virus Minus-Strand RNACorrelation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3aMost common genotypes and risk factors for HCV in Gaza strip: a cross sectional studyVisualizing ATP-Dependent RNA Translocation by the NS3 Helicase from HCVComparison of clinical, virologic and pathologic features in patients with acute hepatitis B and C.Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis.In vitro replication models for the hepatitis C virus.Scotomas in molecular virology and epidemiology of hepatitis C virus.Involvement of a bovine viral diarrhea virus NS5B locus in virion assembly.Downstream processing of cell culture-derived virus particles.Recombinase polymerase amplification as a promising tool in hepatitis C virus diagnosis.Hepatocellular carcinoma: an overview.Synthetic antigens representing the antigenic variation of human hepatitis C virus.Detection of hepatitis C virus transmission by use of DNA mass spectrometry.Dynamic changes in hepatitis C virus genotypes and sequence patterns in plasma donors exposed to reinfection.Assessment of genotype and molecular evolution of hepatitis C virus in formalin-fixed paraffin-embedded liver tissue from patients with chronic hepatitis C virus infection.NS5A mutations predict biochemical but not virological response to interferon-alpha treatment of sporadic hepatitis C virus infection in European patients.Quality of life in HCV-infection: lack of association with ALT levels.The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users.Living with hepatitis C and treatment: the personal experiences of patients.
P2860
Q24300748-4345488D-ED3F-4242-8E6B-02D3AF295432Q24338469-99E92C8F-3C4C-4374-A8C5-EDB29738E645Q27469767-EF3990E3-F577-47AE-9E92-501CE79FBAE6Q27471141-842D2C9A-5557-4311-99B2-682011E8FDF6Q27472862-D016E039-9DDD-449C-94FB-AE995F529B89Q27473515-429CF451-EFD5-4B15-A648-1406C402FE36Q27486521-EB5BBF2D-197C-4461-B69C-7597B74DD5DBQ27489005-4549AD2E-E2D5-461D-998D-7E7F15E545F2Q27666298-A80EA2F7-C180-4884-9688-B808D694050BQ32028431-BC8EFE5C-E179-4679-8672-D01B91BF0BC8Q35886690-58753F35-5C9F-4DEA-9406-0BDBF3D66162Q36703045-EA0E8170-6952-4860-A218-2816E6560F07Q37358620-37790D08-6530-45E4-B29F-D5D2A09DE8DCQ37492821-60FBB8B9-D8B2-400B-9516-932F9597B7B9Q37944322-D420BE00-C262-42BA-91AC-1CFD2C218339Q38302110-74D48886-8AEF-492C-AE87-543A2B835155Q38876753-3D5266FD-D19E-464E-A2D2-C13EA4A4D283Q40669087-4E1C5D75-FAD3-4543-9CA1-72BE2E353CB6Q42279668-BEAAE448-AB9B-4ADE-BC31-79D0619D04DEQ42641864-0F913E31-7932-4D96-89A9-3A39FED34A7DQ42999204-B6212921-C2E7-47A8-9258-312F1D9BA643Q43032777-D1A0174C-B8E3-475C-82BD-4CF8ADD61D72Q43724091-2625EB5B-0204-4FE6-9A90-F8A870C73EC5Q44163628-84C4B65F-A3BF-429A-BFFC-D5ADEE5F59D1Q49140465-4C17206F-8EA1-40F6-916F-D0A0D2374ED6
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The hepatitis C virus: overview.
@en
type
label
The hepatitis C virus: overview.
@en
prefLabel
The hepatitis C virus: overview.
@en
P356
P1433
P1476
The hepatitis C virus: overview.
@en
P2093
P304
P356
10.1002/HEP.510260702
P407
P433
P577
1997-09-01T00:00:00Z